
NEA MANAGEMENT COMPANY, LLC
Latest 13F filing data - Q1 2026
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | SVRA | 24.47M | $133.61M |
![]() | TRVI | 13.22M | $157.74M |
![]() | COUR | 12.87M | $74.89M |
![]() | GLUE | 7.69M | $126.54M |
![]() | BDTX | 4.45M | $9.48M |
![]() | ORIC | 4.12M | $52.18M |
![]() | ZBIO | 4.02M | $78.65M |
![]() | AUPH | 3.97M | $58.83M |
![]() | MBX | 3.61M | $107.89M |
![]() | NKTX | 3.57M | $7.53M |
Arcellx, Inc. | ACLX | 3.05M | $349.66M |
![]() | CELC | 2.29M | $260.87M |
![]() | CVRX | 2.03M | $19.17M |
![]() | PHAT | 1.96M | $21.78M |
![]() | CSBR | 1.71M | $9.85M |
![]() | MRKR | 1.63M | $2.11M |
![]() | IVA | 1.46M | $8.03M |
![]() | KRRO | 1.30M | $14.69M |
![]() | CRSP | 1.06M | $50.36M |
![]() | GOSS | 1.00M | $328.50K |

Savara Inc.
SVRA
Shares Held
24.47M
Value
$133.61M

Trevi Therapeutics, Inc.
TRVI
Shares Held
13.22M
Value
$157.74M

Coursera, Inc.
COUR
Shares Held
12.87M
Value
$74.89M

Monte Rosa Therapeutics, Inc.
GLUE
Shares Held
7.69M
Value
$126.54M

Black Diamond Therapeutics, Inc.
BDTX
Shares Held
4.45M
Value
$9.48M

ORIC Pharmaceuticals, Inc.
ORIC
Shares Held
4.12M
Value
$52.18M

Zenas BioPharma, Inc.
ZBIO
Shares Held
4.02M
Value
$78.65M

Aurinia Pharmaceuticals Inc.
AUPH
Shares Held
3.97M
Value
$58.83M

MBX Biosciences, Inc. Common Stock
MBX
Shares Held
3.61M
Value
$107.89M

Nkarta, Inc.
NKTX
Shares Held
3.57M
Value
$7.53M
Arcellx, Inc.
ACLX
Shares Held
3.05M
Value
$349.66M

Celcuity Inc.
CELC
Shares Held
2.29M
Value
$260.87M

CVRx, Inc.
CVRX
Shares Held
2.03M
Value
$19.17M

Phathom Pharmaceuticals, Inc.
PHAT
Shares Held
1.96M
Value
$21.78M

Champions Oncology, Inc.
CSBR
Shares Held
1.71M
Value
$9.85M

Marker Therapeutics, Inc.
MRKR
Shares Held
1.63M
Value
$2.11M

Inventiva S.A.
IVA
Shares Held
1.46M
Value
$8.03M

Korro Bio, Inc.
KRRO
Shares Held
1.30M
Value
$14.69M

CRISPR Therapeutics AG
CRSP
Shares Held
1.06M
Value
$50.36M

Gossamer Bio, Inc.
GOSS
Shares Held
1.00M
Value
$328.50K
